reboxetine has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (1,3-dipropyl-8-cyclopentylxanthine) | Trials (1,3-dipropyl-8-cyclopentylxanthine) | Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 1,301 | 1 | 165 |
| Protein | Taxonomy | reboxetine (IC50) | 1,3-dipropyl-8-cyclopentylxanthine (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0051 | |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0038 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.2033 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.0234 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogatko, K; Doboszewska, U; Dudka, J; Poleszak, E; Serefko, A; Świąder, K; Szopa, A; Wlaź, A; Wlaź, P; Wośko, S; Wróbel, A; Wyska, E | 1 |
1 other study(ies) available for reboxetine and 1,3-dipropyl-8-cyclopentylxanthine
| Article | Year |
|---|---|
DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests.
Topics: Adenosine A1 Receptor Antagonists; Animals; Antidepressive Agents; Brain; Citalopram; Depression; Drug Interactions; Drug Therapy, Combination; Hindlimb Suspension; Imipramine; Male; Mice; Motor Activity; Reboxetine; Serotonin Antagonists; Xanthines | 2018 |